Novo Nordisk to buy Cardior Pharmaceuticals for up to $1.1 billion
[ COPENHAGEN: Denmark’s Novo Nordisk on Monday said it has agreed to buy Cardior Pharmaceuticals for up to 1.03 billion euros ($1.11 billion) to strengthen its cardiovascular pipeline. The acquisition is in line with the Danish drugmaker’s aim to expand its focus on diabetes and weight-loss therapies to include cardiovascular disease treatments. “By welcoming Cardior … Read more
